Portfolio mapping & regulatory signals
Start from a roster—or from a single ingredient.
Upload products when you have a catalog. Search one substance when you do not. Both routes use the same scored signals; portfolio assessment and Ingredient diligence stay distinct.
- Portfolio risk concentration
- Per-product exposure & ownership
- Scored signals with origin context
Two entry paths
Roster upload or ingredient search
Two entry paths, one workspace: structured signals with provenance, optional portfolio mapping with owners, and optional Ingredient diligence drafts for human review.
I have a roster
Operators run intake and validation; assessment joins products to signals for exposure and ownership—leadership sees concentration, teams work the rows.
Canonical product record
Signal generation
Portfolio assessment
Dashboards & handoff
I have an ingredient
No roster required. Resolve a substance, inspect corpus and signal evidence, then draft an Ingredient diligence brief for human review. This is not M&A diligence and not legal advice.
Search & resolve
Products, signals, jurisdictions
Ingredient diligence draft
Getting started
Offerings
Pick the path that matches how you work today. Individual access includes signals, ingredient research, Ingredient diligence drafts, and portfolio mapping. Institutional programs add the Governance suite.
Individual access
Self-service for practitioners: prepaid tokens or usage billing, phone sign-in, and SMS verification. Start auditing when you are ready to open the workspace.
Start auditing →
Institutional access
Enterprise programs with fit and governance review, provisioned workspace access, admin portal, Compliance (PCR), Controls (GRC), Suppliers (TPRM), M&A diligence, and optional white-label or API integration.
Request access →
Governance & access
Signals stay tied to evidence; ingredient research needs no roster; portfolio impact stays owned—built for operator review, not opaque alerts.
Start auditing when you are ready, or request institutional access for enterprise onboarding.
- Human-in-the-loop review stays in operator workflows.
- Recommendations remain evidence-linked and auditable.
- Portfolio mapping is role-aware with explicit ownership.